Bosnjak S, Zilic A, Radhakrishnan V, Ostwal V, Aapro M, Iihara H
Support Care Cancer. 2025; 33(3):181.
PMID: 39937269
DOI: 10.1007/s00520-025-09211-4.
Xiao J, Zhang M, Wu D
J Biol Methods. 2024; 11(3):e99010018.
PMID: 39544189
PMC: 11557297.
DOI: 10.14440/jbm.2024.0019.
Shinomiya Y, Kouchi Y, Harada-Kagitani S, Ishige T, Takano S, Ohtsuka M
Cancer Sci. 2024; 115(6):1948-1963.
PMID: 38613239
PMC: 11145149.
DOI: 10.1111/cas.16175.
Ullah I, Ayaz M
Pharmacol Rep. 2023; 75(5):1126-1137.
PMID: 37584820
DOI: 10.1007/s43440-023-00514-z.
Piechotta V, Adams A, Haque M, Scheckel B, Kreuzberger N, Monsef I
Cochrane Database Syst Rev. 2021; 11:CD012775.
PMID: 34784425
PMC: 8594936.
DOI: 10.1002/14651858.CD012775.pub2.
Suppression of Cisplatin-Induced Vomiting by in Pigeons: Neurochemical Evidences.
Ullah I, Subhan F, Alam J, Shahid M, Ayaz M
Front Pharmacol. 2018; 9:231.
PMID: 29615907
PMC: 5865282.
DOI: 10.3389/fphar.2018.00231.
[Chemotherapy-induced nausea and vomiting : Current recommendations for prophylaxis].
Storz E, Gschwend J, Retz M
Urologe A. 2018; 57(5):532-542.
PMID: 29589051
DOI: 10.1007/s00120-018-0606-6.
CINV: still troubling patients after all these years.
Aapro M
Support Care Cancer. 2018; 26(Suppl 1):5-9.
PMID: 29556808
PMC: 5876280.
DOI: 10.1007/s00520-018-4131-3.
The role of neurokinin-1 (substance P) antagonists in the prevention of postoperative nausea and vomiting.
Okafor D, Kaye A, Kaye R, Urman R
J Anaesthesiol Clin Pharmacol. 2018; 33(4):441-445.
PMID: 29416232
PMC: 5791253.
DOI: 10.4103/0970-9185.222511.
Analysis of Dietary Intake during Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas.
Hori Y, Sakamoto A, Goto T, Ando S, Yamashita M, Shimomura M
Front Nutr. 2018; 4:70.
PMID: 29404330
PMC: 5786570.
DOI: 10.3389/fnut.2017.00070.
Moxibustion for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis.
Huang Z, Qin Z, Yao Q, Wang Y, Liu Z
Evid Based Complement Alternat Med. 2017; 2017:9854893.
PMID: 29234451
PMC: 5660813.
DOI: 10.1155/2017/9854893.
Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study.
Vazin A, Eslami D, Sahebi E
Ther Clin Risk Manag. 2017; 13:1151-1157.
PMID: 28919769
PMC: 5592905.
DOI: 10.2147/TCRM.S133820.
Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery).
Vayne-Bossert P, Haywood A, Good P, Khan S, Rickett K, Hardy J
Cochrane Database Syst Rev. 2017; 7:CD012002.
PMID: 28671265
PMC: 6379017.
DOI: 10.1002/14651858.CD012002.pub2.
Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer.
Hsu H, Tsai S, Wu S, Jeang S, Ho M, Liou W
Support Care Cancer. 2017; 25(11):3457-3464.
PMID: 28634657
DOI: 10.1007/s00520-017-3768-7.
Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study.
Yang L, Sun X, Qin S, Cheng Y, Shi J, Chen Z
Eur J Cancer Care (Engl). 2017; 26(6).
PMID: 28393417
PMC: 5697660.
DOI: 10.1111/ecc.12668.
Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy.
Koshiyama M, Matsumura N, Imai S, Yamanoi K, Abiko K, Yoshioka Y
Med Sci Monit. 2017; 23:826-833.
PMID: 28198358
PMC: 5322867.
DOI: 10.12659/msm.899741.
A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab.
Affronti M, Woodring S, Peters K, Herndon 2nd J, McSherry F, Healy P
Ther Clin Risk Manag. 2017; 13:33-40.
PMID: 28096679
PMC: 5207433.
DOI: 10.2147/TCRM.S122480.
Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy.
Kusaba H, Kumagai H, Inadomi K, Matsunobu T, Harimaya K, Takayoshi K
Medicine (Baltimore). 2016; 95(49):e5460.
PMID: 27930525
PMC: 5265997.
DOI: 10.1097/MD.0000000000005460.
A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen.
Miyata Y, Yakushijin K, Inui Y, Imamura Y, Goto H, Mizutani Y
Int J Hematol. 2016; 104(6):682-691.
PMID: 27612464
DOI: 10.1007/s12185-016-2089-9.
2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children.
Dupuis L, Sung L, Molassiotis A, Orsey A, Tissing W, van de Wetering M
Support Care Cancer. 2016; 25(1):323-331.
PMID: 27565788
DOI: 10.1007/s00520-016-3384-y.
